2cb, also known with its street names of 7th heaven, 7-up, Blue Mystic, Lucky 7 and Tripstasy, is a psychedelic drug which affects a person’s cognition and perception of reality. Its chemical makeup is 4-bromo-2, 5-dimethoxyphenethylamine and is included in the 2C family, a group of hallucinogenic drugs. 2cb usually takes the form of white powder which can be intake orally or inhaled but can also be sold as tablets or gel caps. Alexander Shulgin, an American pharmacologist and drug developer, was the man responsible for creating 2cb in 1974 as a form of therapy for psychiatric patients.
2cb Medical And Miscellaneous Uses
2cb was effective for this use because of minimal and short duration of side effects. It has also become a popular drug to induce aphrodisiac effects. Legally, a prescription from a certified health care practitioner such as doctors is needed to acquire and buy 2cb. This drug is taken in for complimentary effects to ectasy. It somehow works similar to amphetamines or psychoactive substance which positively stimulates meaning, increases neural activities of a person causing change in behavior and mental state.
The onset of effects of 2cb is comparatively fast in a span of 20 to 90 minutes after being ingested or smoked. It will peak after 15 to 30 minutes of ingestion or inhalation. The next stage called plateau will usually last for 2 to 3 hours which is influenced by the dosage of the drug. It may also differ whether it is taken in orally or not because inhalation is more rapid as compared to ingestion. The heightened response of the body is then taken down after 2 hours and ultimately, only aftereffects are felt in the duration of 2 to 4 hours.
When insufflated, the onset, or ‘coming up’, happens very rapidly, usually reaching the peak at about 20–40 minutes lasting anywhere from 30 minutes to a few hours depending on dosage. When orally consumed, 2C-B has a much longer delay before the onset of effects than when it is insufflated. Oral ingestion generally takes roughly 30–90 minutes for the effects to be felt; while with insufflation the onset may be immediate. 2C-B is also considered one of the most painful drugs to insufflate, with users almost always reporting intense nasal burning lasting as long as 5 minutes.
- This radical change is not usually overwhelming to most users, but the intensity of the experience can make them nauseated and/or frightened. Plateau effects are reached in about 20-40 min and last for about 2–3 hours, but this also depends on the method of ingestion: with insufflation the effects are more abrupt and intense but have a significantly shorter duration, while oral usage will result in a milder longer experience. The ‘rush’ that users feel off MDMA and grinding of teeth is often reported in less experienced users.
The visuals ‘waver’ or come and go in a carousel-like pattern meaning that when the effect is strong then dies down, users may feel that the trip is over, only for it to come back stronger. The duration as a whole, though is only about 2–5 hours depending on dosage.
- Some users report aphrodisiac effects at lower doses (5–10 mg).
- At 5–10 mg, experiments with young chickens have shown it to produce effects similar to a low dosage of amphetamines.
- At higher dosages (greater than 15 mg) some users consider the hallucinations a “turn-off” or distracting.
- The hallucinations have a tendency to decrease and then increase in intensity, giving the users a sense of “waves” or even glowing. These are popularly described as “clichéd ’70s visuals” or objects taking on "water color" like textures. Other users have noted DMT-like "brain movies".
- While the effects of the drug often render users unable to concentrate deeply on anything in particular, some can become engrossed in an activity such as watching a movie or playing a video game, distracting themselves from the visual and auditory effects of the drug.
- Excessive giggling or smiling is common, as is a tendency for deeper “belly laughs”. Some users report mild “jitters” (body tremors), shuddering breath, and/or mild muscle spasms after snorting (not immediate). Whether or not these effects are enjoyable depends on the user.
- Some users say that the effects are more intense when listening to music and report that they can see sounds and noises.
- Some users experience a decrease in visual acuity, although others report sharper vision.
- At low doses the experience may shift in intensity from engaging to mild/undetectable. Experienced users report the ability to take control of the effects and switch from engaged to sober at will.
- Increased awareness of one’s body; attention may be brought to perceived ‘imperfections’ or internal body processes.
- Possible side effects include: mild diarrhea, gas, and nausea. Some users have said to experience a slight irritability for roughly a day or so after use. However, these effects are rare and the drug is generally easier on the body than MDMA (Ecstasy).
- Severe headaches after coming down from large doses have been reported. However, many users report a lack of “comedown” or “crash”, instead noting a gradual return to sobriety. There are reports of hangover effects, especially when the drug is combined with alcohol.
- At doses over 30/40 mg the user may experience frightening hallucinations inducing tachycardia, hypertension and hyperthermia.
· 2C-B is used by the same population as those using "Ecstasy" and other club drugs, high school and college students, and other young adults who frequent "rave" or "techno" parties.
1^ "List of psychotropic substances under international control" (PDF). Archived from the original on 2 March 2007. http://www.incb.org/pdf/e/list/green.pdf. Retrieved 2007-03-30.
2^ "2C-B (Nexus) Reappears on the Club Drug Scene" (Press release). Drug Enforcement Administration. May 2001. Archived from the original on 5 October 2006. http://www.usdoj.gov/ndic/pubs0/665/index.htm. Retrieved 2006-10-04.
3^ "Erowid 2C-B Vault : Dose/Dosage". http://www.erowid.org/chemicals/2cb/2cb_dose.shtml.
4^ Ambrose JB, Bennett HD, Lee HS, Josephson SA (May 2010). "Cerebral vasculopathy after 4-bromo-2,5-dimethoxyphenethylamine ingestion". The Neurologist 16 (3): 199–202. doi:10.1097/NRL.0b013e3181a3cb53. PMID 20445431.
5^ Bronson ME, Jiang W, DeRuiter J, Clark CR (1995). "A behavioral comparison of Nexus, cathinone, BDB, and MDA". Pharmacol. Biochem. Behav. 51 (2–3): 473–5. doi:10.1016/0091-3057(95)00013-M. PMID 7667371.
6^ Carmo H, Hengstler JG, de Boer D, et al (January 2005). "Metabolic pathways of 4-bromo-2,5-dimethoxyphenethylamine (2C-B): analysis of phase I metabolism with hepatocytes of six species including human". Toxicology 206 (1): 75–89. doi:10.1016/j.tox.2004.07.004. PMID 15590110. http://linkinghub.elsevier.com/retrieve/pii/S0300-483X(04)00396-8.